Enterix Inc, based in Edison Twp, NJ, offers InSure One, a convenient and non-invasive fecal immunochemical test (FIT) for colorectal cancer screening. This preventative screening method allows individuals to collect a water-based sample from a single bowel movement in the comfort of their own homes, eliminating the need for special preparation or dietary changes.
With the aim of early detection and prevention, InSure One detects both invasive tumors and potentially precancerous lesions, helping to reduce colorectal cancer-related deaths. The test is recommended by the American Cancer Society for individuals at average risk, starting at age 45. By providing reassuring results and easy-to-follow instructions, Enterix Inc strives to make colorectal cancer screening accessible and effective.
Generated from the website